Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Enviri Corporation (NYSE: NVRI), a leading environmental and operational solutions provider in the metal and rail industries, announced its management will participate in the Jefferies Global Industrials Conference and the Lake Street Best Ideas Growth Conference in New York on September 9 and 10, 2026 respectively. The participation underscores En…
CytomX Therapeutics announced that the FDA has granted Fast Track Designation to its investigational drug Varsetatug masetecan (Varseta-M) for treating relapsed/refractory metastatic colorectal cancer (R/R mCRC). This designation follows encouraging Phase 1 data and is intended to expedite development and review. CytomX plans to initiate a registra…
Artelo Biosciences, a clinical-stage pharmaceutical company, declared a 1-for-9 reverse stock split of its common stock effective August 31, 2026. This corporate action aims to increase the stock price per share to enhance liquidity and marketability without changing shareholder ownership percentages. All outstanding warrants and derivatives will b…
Red Violet, Inc., a leading identity intelligence and analytics company, announced its participation at Citi's 2026 Global TMT Conference. The company’s CEO and CFO will present and host investor meetings, highlighting its proprietary identity intelligence technologies and AI-powered platform CORE™ used for identity verification, risk mitigation, a…
PodcastOne has acquired exclusive sales and distribution rights to the entertainment podcast ‘Dropping Names… and Other Things with Brent & Jonny,’ hosted by actors Brent Spiner and Jonathan Frakes. This deal expands PodcastOne's portfolio with its 12th new podcast addition this year, broadening its reach in the entertainment podcast sector and enh…
SL Science Holding Limited filed a new Drug Master File with the FDA covering exosomes derived from Gamma Delta T cells. This expands their regulatory documentation beyond just the GDT cells to include the cell-free exosomes, potentially accelerating future development programs. The exosome format may overcome delivery challenges in oncology, notab…
Deutsche Bank analysts, led by Carolin Raab, warn that joining the DAX often fails to deliver sustained share-price outperformance. With STOXX set to review the index on September 3 and changes effective September 21, Lufthansa remains a candidate to rejoin but has seen its prospects dim after Fresenius Medical Care's free-float increase pushed it …
UBS strategists argue that commodity allocations should reach beyond energy into industrial metals, agricultural crops and gold, citing long-term demand drivers and inflation protection. The bank notes ongoing volatility in energy markets, strong El Nino odds for weather-driven crop risks, and central bank activity supporting bullion.
Siemens Energy has pushed through a painful restructuring cycle. With improved execution across Gas, Grid, and Siemens Gamesa, the stock looks primed for a tactical long. This trade targets a recovery driven by backlog conversion, better margin trajectory and falling working capital pressure.
Zymeworks is shifting its identity from a development-stage biotech to a hybrid commercial/royalty-driven platform. With licensed assets in the mix, a $929M acquisition of Theravance (bringing YUPELRI® with $266.6M in 2025 U.S. sales), fresh commercial upside and a deeper R&D bench, the company has optionality that could justify a higher multiple. …
Okta's fundamentals and guidance from the May quarter keep the buy case intact: 11% revenue growth in Q1 to $765M, $271M of FCF in the quarter and a FY27 revenue guide near $3.2B. However, the stock now trades at a premium (EV/sales ~7.7, trailing P/E ~95) and recent outperformance narrows the margin for execution mistakes. This trade proposes a di…
AT&T trades at $25.89 with a 4.5% yield, a single-digit P/E and an EV/EBITDA of ~6.5. The balance sheet still carries leverage, but free cash flow of ~$13.3B and a 36-45% payout framework make the dividend resilient. This trade targets a reversion toward the 52-week high and a modest re-rating as subscriber stability, cash flow and buybacks normali…
Amkor Technology shares jumped sharply in pre-market trading after BofA Securities began coverage with a Buy rating and a $70 price target, citing expected EPS growth, improving factory utilization and a move toward higher-value packaging products. The bank’s view, coupled with Amkor’s record second-quarter performance and strategic agreements with…
Royal Bank of Canada shares rose in pre-open trading after the bank reported record fiscal third-quarter 2026 results. Adjusted net income and adjusted diluted EPS topped expectations, driven by gains in Wealth Management, Capital Markets and Commercial Banking. Analyst upgrades and a positive broader market tone contributed to the stock's early ga…
Bloom Energy is trading like a growth juggernaut after a string of blowout quarters and a $20 billion backlog. Fundamentals justify the story, but the valuation is demanding. This is a structured swing trade: respect the premium, limit position size, and use a tight stop to capture a potential re-rating while protecting against profit-taking.
Waste Management is a high-quality compounder: strong ROE (28.7%), predictable free cash flow ($3.57B), and essential services that keep revenue resilient in downturns. At $221, the stock is priced richly (P/E ~31, P/B ~8.9, EV/EBITDA ~14.3). This trade idea recommends waiting for a pullback to $205 to initiate a position, using a $195 stop, and ta…
Corvus Pharmaceuticals announced the publication of final Phase 1/1b clinical trial data for its investigational drug soquelitinib, demonstrating promising anti-tumor activity and durable responses in patients with refractory T cell lymphoma. The data, published in the journal Blood, support ongoing Phase 3 and Phase 2 trials for various indication…
Caliber, a Nasdaq-listed real estate-focused alternative asset manager, announced the launch of Caliber Tokenization Services (CTS), a new division providing full-service real-world asset tokenization to family offices with significant real estate holdings. Following initial successful tokenization of its own portfolio, Caliber aims to simplify own…
Veea Inc., a Nasdaq-listed leader in AI-driven edge infrastructure, has signed a Technology Services Distribution Agreement with Telarus, a prominent technology services distributor. This partnership aims to expand Veea's secure connectivity, edge computing, and AI-enabled technology solutions through Telarus's extensive network of technology advis…
3D Systems announced a strategic partnership with Savannah River National Laboratory (SRNL) through a Cooperative Research and Development Agreement to advance additive manufacturing technologies targeting advanced energy generation, including nuclear energy, and national security applications. The collaboration will focus on developing advanced ma…
BrainsWay Ltd. announced peer-reviewed data demonstrating that their Deep Transcranial Magnetic Stimulation (Deep TMS) treatment achieves a 70% relative reduction in patients experiencing suicidal ideation among those with Major Depressive Disorder (MDD). The study, published in the Journal of Affective Disorders, also highlights that their acceler…
Nexalin Technology, Inc. approved and is implementing a 1-for-30 reverse stock split of its common stock effective August 28, 2026, to maintain compliance with Nasdaq bid-price requirements. The stock will continue trading under ticker NXL on Nasdaq from August 31, 2026. The company designs neurostimulation medical devices targeting mental health d…
Wendy’s premarket shares plunged after reports that Trian Fund Management has stepped away from pursuing a take-private transaction. Sources told Reuters the investment firm cited concerns about the company’s trading price, valuation multiples and strategic direction. The move reverses momentum that had pushed the stock higher earlier this month wh…
Celestica's role as an assembler of complex AI server racks and its strong Q1 print and raised guidance position it to benefit disproportionately if the so-called 'Jalapeño' AI chip ramps hit hyperscalers. Valuation is elevated but not prohibitive given $19B revenue guidance and robust profitability metrics. We upgrade to Buy and outline a mid-term…
Urban Outfitters is delivering above-consensus results, expanding margins and converting subscription strength into healthier cash flow. The shares trade at a reasonable multiple against steady fundamentals and improving operating metrics. We upgrade to a buy and propose a clear swing trade: entry $83.00, target $95.00, stop $74.00 over a 45 tradin…
